A detailed history of Levin Capital Strategies, L.P. transactions in 23and Me Holding Co. stock. As of the latest transaction made, Levin Capital Strategies, L.P. holds 730,000 shares of ME stock, worth $2.37 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
730,000
Previous 155,000 370.97%
Holding current value
$2.37 Million
Previous $60,000 325.0%
% of portfolio
0.02%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$0.29 - $0.51 $166,750 - $293,250
575,000 Added 370.97%
730,000 $255,000
Q2 2024

Aug 07, 2024

BUY
$0.36 - $0.61 $55,800 - $94,550
155,000 New
155,000 $60,000
Q2 2022

Aug 15, 2022

SELL
$2.19 - $3.98 $10,950 - $19,900
-5,000 Reduced 23.26%
16,500 $41,000
Q1 2022

May 02, 2022

SELL
$3.28 - $7.12 $93,480 - $202,920
-28,500 Reduced 57.0%
21,500 $82,000
Q4 2021

Feb 15, 2022

BUY
$6.55 - $13.25 $327,500 - $662,500
50,000 New
50,000 $333,000

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $842M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track Levin Capital Strategies, L.P. Portfolio

Follow Levin Capital Strategies, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Levin Capital Strategies, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Levin Capital Strategies, L.P. with notifications on news.